Figure 7 shows the Kaplan–Meier survival curves for NDMI score split at the median in the test set’s isocitrate dehydrogenase (IDH) wildtype GBM and IDH-wildtype astrocytoma patients, in each subtype survival times were statistically significantly different. The gene discussed is IDH3A; the disease is glioblastoma.